Evaluation of CD46 re-targeted adenoviral vectors for clinical ovarian cancer intraperitoneal therapy.

Cancer Gene Ther · 2016 · PMC4947523 · PMID 27229159

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significanceP =0.06so close (0.05 < p ≤ 0.1)

We observed an increase in transduction of EOCs by Ad5T*F35++ vector (5000 vp per cell) in comparison to the parental Ad5 vector, although this did not reach statistical significance ( P =0.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.